Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
BMI and hyperphagia reductions have been observed in patients with PWS treated with setmelanotide at Month 3 (n=8) and Month 6 (n=5); 17 of 18 ...
Rhythm Pharmaceuticals, Inc. (RYTM) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends ...
The Alpha-Stim device helps reduce anxiety, depression, and insomnia symptoms through cranial electrotherapy stimulation. Alpha-Stim devices are considered safe with minimal side effects reported in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results